YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Internet Treatment for Weight Loss in Primary Care

Not Applicable

Completed

Conditions: Overweight
Obese

Interventions: Behavioral: Motivational Interviewing
Behavioral: Treatment as usual with primary care physician
Behavioral: Nutritional Counseling

First Posted Date: 2012-03-20

Last Posted Date: 2015-07-01

Lead Sponsor: Yale University

Target Recruit Count: 89

Registration Number: NCT01558297

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

Genetic Effect on Omega 3 Fatty Acids for the Treatment of Fatty Liver Disease

Not Applicable

Completed

Conditions: Steatohepatitis
Hypertriglyceridemia
Non Alcoholic Fatty Liver Disease
Alanine Aminotransferase, Plasma Level of, Quantitative Trait Locus 1

Interventions: Other: Omega diet

First Posted Date: 2012-03-16

Last Posted Date: 2017-04-28

Lead Sponsor: Yale University

Target Recruit Count: 17

Registration Number: NCT01556113

Locations: 🇺🇸
Yale School of Medicine, New Haven, Connecticut, United States

The Role of Stress in Self-Control, Coping, and Emotion Regulation

Completed

Conditions: Stress

First Posted Date: 2012-03-15

Last Posted Date: 2016-11-30

Lead Sponsor: Yale University

Target Recruit Count: 855

Registration Number: NCT01554501

Locations: 🇺🇸
Yale Stress Center, New Haven, Connecticut, United States

Varenicline Treatment of Alcohol Dependence in Smokers

Phase 2

Completed

Conditions: Alcoholism
Alcohol Abuse
Smoking
Alcohol Drinking

Interventions: Drug: Varenicline

First Posted Date: 2012-03-13

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 131

Registration Number: NCT01553136

Locations: 🇺🇸
Connecticut Mental Health Center - Substance Abuse Treatment Unit, New Haven, Connecticut, United States
🇺🇸
Parallax Center, New York, New York, United States

HIV, Buprenorphine, and the Criminal Justice System

Not Applicable

Completed

Conditions: Opiate Addiction
Human Immunodeficiency Virus
Acquired Immunodeficiency Syndrome
Drug Dependence

Interventions: Drug: Buprenorphine/naloxone
Drug: Placebo Oral Tablet

First Posted Date: 2012-03-12

Last Posted Date: 2020-05-06

Lead Sponsor: Yale University

Target Recruit Count: 50

Registration Number: NCT01550341

Locations: 🇺🇸
Howard University, Washington, District of Columbia, United States

Ketamine for Depression and Alcohol Dependence

Phase 1

Completed

Conditions: Depression
Alcohol Dependence

Interventions: Drug: Ketalar (ketamine)

First Posted Date: 2012-03-12

Last Posted Date: 2020-03-09

Lead Sponsor: Yale University

Target Recruit Count: 5

Registration Number: NCT01551329

Locations: 🇺🇸
VA CT Healthcare Systems, West Haven, Connecticut, United States

Guanfacine in Children With Tic Disorders

Phase 4

Completed

Conditions: Tourette Disorder
Tourette Syndrome

Interventions: Drug: placebo
Drug: extended-release guanfacine (Intuniv)

First Posted Date: 2012-03-07

Last Posted Date: 2021-08-13

Lead Sponsor: Yale University

Target Recruit Count: 34

Registration Number: NCT01547000

Locations: 🇺🇸
University of South Florida, Tampa, Florida, United States
🇺🇸
Mount Sinai School of Medicine, New York, New York, United States
🇺🇸
Yale Child Study Center, New Haven, Connecticut, United States

Integrated Brain, Body and Social Intervention for Attention Deficit Hyperactivity Disorder (ADHD)

Not Applicable

Completed

Conditions: Attention Deficit Hyperactivity Disorder (ADHD)

Interventions: Behavioral: IBBS

First Posted Date: 2012-03-02

Last Posted Date: 2018-01-17

Lead Sponsor: Yale University

Target Recruit Count: 117

Registration Number: NCT01542528

Locations: 🇺🇸
Department of Psychiatry, Yale University, New Haven, Connecticut, United States
🇨🇳
Capital Medical University, Beijing, Beijing, China
🇨🇳
Peking University, Beijing, Beijing, China

and more 2 locations

Screening to Augment Referral to Treatment- Project START

Not Applicable

Completed

Conditions: Alcohol Abuse
Tobacco Use Disorder
Substance-Related Disorders
Marijuana Abuse

Interventions: Behavioral: Motivational Interview
Other: Treatment as Usual

First Posted Date: 2012-02-27

Last Posted Date: 2017-04-14

Lead Sponsor: Yale University

Target Recruit Count: 439

Registration Number: NCT01539525

Locations: 🇺🇸
Yale-New Haven Hospital- York St Campus, New Haven, Connecticut, United States
🇺🇸
Yale-New Haven Hospital-Chapel St Campus, New Haven, Connecticut, United States

Cognitive Enhancement as a Target for Cocaine Pharmacotherapy

Not Applicable

Completed

Conditions: Addiction

Interventions: Drug: Placebo
Drug: Galantamine

First Posted Date: 2012-02-10

Last Posted Date: 2018-10-26

Lead Sponsor: Yale University

Target Recruit Count: 93

Registration Number: NCT01531153

Locations: 🇺🇸
Department of Veterans Affairs, West Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy